No Data
No Data
Express News | Aditxt Announces Third Amendment to Arrangement Agreement With Appili Therapeutics
Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction With Aditxt
Evofem Biosciences Addresses Impact Of GLP-1 Medications On Oral Contraceptive Absorption And Introduces Phexxi As A Non-Oral Solution
Aditxt | 10-Q: Q2 2024 Earnings Report
Looking Into Aditxt's Recent Short Interest
Evofem Biosciences Had $700,000 of Restricted Cash at June 30 >EVFM
No Data